{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T09:31:19Z","timestamp":1793871079793,"version":"4.6.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,2,7]],"date-time":"2018-02-07T00:00:00Z","timestamp":1517961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,2,7]],"date-time":"2018-02-07T00:00:00Z","timestamp":1517961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hepatic fibrosis is the result of an excessive wound-healing response subsequent to chronic liver injury. A feature of liver fibrogenesis is the secretion and deposition of extracellular matrix proteins by activated hepatic stellate cells (HSCs). Here we report that upregulation of EphB2 is a prominent feature of two mouse models of hepatic fibrosis and also observed in humans with liver cirrhosis. EphB2 is upregulated and activated in mouse HSCs following chronic carbon tetrachloride (CCl<jats:sub>4<\/jats:sub>) exposure. Moreover, we show that EphB2 deficiency attenuates liver fibrosis and inflammation and this is correlated with an overall reduction in pro-fibrotic markers, inflammatory chemokines and cytokines. In an <jats:italic>in vitro<\/jats:italic> system of HSCs activation we observed an impaired proliferation and sub-optimal differentiation into fibrogenic myofibroblasts of HSCs isolated from <jats:italic>EphB2\u2212\/<\/jats:italic>\u2212 mice compared to HSCs isolated from wild type mice. This supports the hypothesis that EphB2 promotes liver fibrosis partly via activation of HSCs. Cellular apoptosis which is generally observed during the regression of liver fibrogenesis was increased in liver specimens of CCl<jats:sub>4<\/jats:sub>-treated <jats:italic>EphB2\u2212\/<\/jats:italic>\u2212 mice compared to littermate controls. This data is suggestive of an active repair\/regeneration system in the absence of EphB2. Altogether, our data validate this novel pro-fibrotic function of EphB2 receptor tyrosine kinase.<\/jats:p>","DOI":"10.1038\/s41598-018-20926-9","type":"journal-article","created":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T10:11:21Z","timestamp":1517479881000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["EphB2 receptor tyrosine kinase promotes hepatic fibrogenesis in mice via activation of hepatic stellate cells"],"prefix":"10.1038","volume":"8","author":[{"given":"Patrice N.","family":"Mimche","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Choon M.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie M.","family":"Mimche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Thapa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Grakoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Henkemeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracey J.","family":"Lamb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,7]]},"reference":[{"key":"20926_CR1","doi-asserted-by":"publisher","first-page":"167sr161","DOI":"10.1126\/scitranslmed.3004700","volume":"5","author":"SL Friedman","year":"2013","unstructured":"Friedman, S. L., Sheppard, D., Duffield, J. S. & Violette, S. Therapy for Fibrotic Diseases: Nearing the Starting Line. Science Translational Medicine 5, 167sr161\u2013167sr161, https:\/\/doi.org\/10.1126\/scitranslmed.3004700 (2013).","journal-title":"Science Translational Medicine"},{"key":"20926_CR2","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1172\/JCI66028","volume":"123","author":"D Schuppan","year":"2013","unstructured":"Schuppan, D. & Kim, Y. O. Evolving therapies for liver fibrosis. The Journal of Clinical Investigation 123, 1887\u20131901, https:\/\/doi.org\/10.1172\/JCI66028 (2013).","journal-title":"The Journal of Clinical Investigation"},{"key":"20926_CR3","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","volume":"134","author":"SL Friedman","year":"2008","unstructured":"Friedman, S. L. Mechanisms of Hepatic Fibrogenesis. Gastroenterology 134, 1655\u20131669, https:\/\/doi.org\/10.1053\/j.gastro.2008.03.003 (2008).","journal-title":"Gastroenterology"},{"key":"20926_CR4","doi-asserted-by":"publisher","unstructured":"Kisseleva, T. The origin of fibrogenic myofibroblasts in fibrotic liver. Hepatology, n\/a\u2013n\/a, https:\/\/doi.org\/10.1002\/hep.28948 (2017).","DOI":"10.1002\/hep.28948"},{"key":"20926_CR5","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1055\/s-0035-1554915","volume":"35","author":"RG Wells","year":"2015","unstructured":"Wells, R. G. & Schwabe, R. F. Origin and Function of Myofibroblasts in the Liver. Semin Liver Dis 35, e1\u2013e1, https:\/\/doi.org\/10.1055\/s-0035-1554915 (2015).","journal-title":"Semin Liver Dis"},{"key":"20926_CR6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1172\/JCI88881","volume":"127","author":"Y Koyama","year":"2017","unstructured":"Koyama, Y. & Brenner, D. A. Liver inflammation and fibrosis. J Clin Invest 127, 55\u201364 (2017).","journal-title":"J Clin Invest"},{"key":"20926_CR7","doi-asserted-by":"publisher","first-page":"R90","DOI":"10.1016\/j.cub.2017.01.003","volume":"27","author":"H Taylor","year":"2017","unstructured":"Taylor, H., Campbell, J. & Nobes, C. D. Ephs and ephrins. Current Biology 27, R90\u2013R95, https:\/\/doi.org\/10.1016\/j.cub.2017.01.003 (2017).","journal-title":"Current Biology"},{"key":"20926_CR8","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1126\/science.2825356","volume":"238","author":"H Hirai","year":"1987","unstructured":"Hirai, H., Maru, Y., Hagiwara, K., Nishida, J. & Takaku, F. A novel putative tyrosine kinase receptor encoded by the eph gene. Science 238, 1717\u20131720 (1987).","journal-title":"Science"},{"key":"20926_CR9","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1146\/annurev-pharmtox-011112-140226","volume":"55","author":"A Barquilla","year":"2015","unstructured":"Barquilla, A. & Pasquale, E. B. Eph receptors and ephrins: therapeutic opportunities. Annu Rev Pharmacol Toxicol 55, 465\u2013487 (2015).","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"20926_CR10","doi-asserted-by":"publisher","unstructured":"Lisabeth, E. M., Falivelli, G. & Pasquale, E. B. Eph Receptor Signaling and Ephrins. Cold Spring Harbor Perspectives in Biology 5, https:\/\/doi.org\/10.1101\/cshperspect.a009159 (2013).","DOI":"10.1101\/cshperspect.a009159"},{"key":"20926_CR11","doi-asserted-by":"publisher","first-page":"6452","DOI":"10.1158\/0008-5472.CAN-16-1521","volume":"76","author":"E Shiuan","year":"2016","unstructured":"Shiuan, E. & Chen, J. Eph Receptor Tyrosine Kinases in Tumor Immunity. Cancer Research 76, 6452\u20136457, https:\/\/doi.org\/10.1158\/0008-5472.can-16-1521 (2016).","journal-title":"Cancer Research"},{"key":"20926_CR12","doi-asserted-by":"publisher","first-page":"e14845","DOI":"10.7554\/eLife.14845","volume":"5","author":"B Krusche","year":"2016","unstructured":"Krusche, B. et al. EphrinB2 drives perivascular invasion and proliferation of glioblastoma stem-like cells. eLife 5, e14845, https:\/\/doi.org\/10.7554\/eLife.14845 (2016).","journal-title":"eLife"},{"key":"20926_CR13","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.humpath.2013.10.001","volume":"45","author":"Q Gao","year":"2014","unstructured":"Gao, Q. et al. EphB2 promotes cervical cancer progression by inducing epithelial-mesenchymal transition. Human Pathology 45, 372\u2013381, https:\/\/doi.org\/10.1016\/j.humpath.2013.10.001 (2014).","journal-title":"Human Pathology"},{"key":"20926_CR14","doi-asserted-by":"publisher","first-page":"2961","DOI":"10.1002\/jcp.25025","volume":"230","author":"MJ Serrano","year":"2015","unstructured":"Serrano, M. J., Liu, J., Svoboda, K. K. H., Nawshad, A. & Benson, M. D. Ephrin reverse signaling mediates palatal fusion and epithelial-to-mesenchymal transition independently of tgf\u00df3. Journal of Cellular Physiology 230, 2961\u20132972, https:\/\/doi.org\/10.1002\/jcp.25025 (2015).","journal-title":"Journal of Cellular Physiology"},{"key":"20926_CR15","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1002\/path.1937","volume":"208","author":"J Zhang","year":"2006","unstructured":"Zhang, J. & Hughes, S. E. Role of the ephrin and Eph receptor tyrosine kinase families in angiogenesis and development of the cardiovascular system. The Journal of Pathology 208, 453\u2013461, https:\/\/doi.org\/10.1002\/path.1937 (2006).","journal-title":"The Journal of Pathology"},{"key":"20926_CR16","doi-asserted-by":"publisher","first-page":"G908","DOI":"10.1152\/ajpgi.00510.2009","volume":"298","author":"A Das","year":"2010","unstructured":"Das, A. et al. Ephrin B2\/EphB4 pathway in hepatic stellate cells stimulates Erk-dependent VEGF production and sinusoidal endothelial cell recruitment. American Journal of Physiology - Gastrointestinal and Liver Physiology 298, G908\u2013G915, https:\/\/doi.org\/10.1152\/ajpgi.00510.2009 (2010).","journal-title":"American Journal of Physiology - Gastrointestinal and Liver Physiology"},{"key":"20926_CR17","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1053\/j.gastro.2008.04.010","volume":"135","author":"D Semela","year":"2008","unstructured":"Semela, D. et al. Platelet-Derived Growth Factor Signaling Through Ephrin-B2 Regulates Hepatic Vascular Structure and Function. Gastroenterology 135, 671\u2013679.e672, https:\/\/doi.org\/10.1053\/j.gastro.2008.04.010 (2008).","journal-title":"Gastroenterology"},{"key":"20926_CR18","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1373\/clinchem.2003.026849","volume":"50","author":"C Hafner","year":"2004","unstructured":"Hafner, C. et al. Differential Gene Expression of Eph Receptors and Ephrins in Benign Human Tissues and Cancers. Clinical Chemistry 50, 490\u2013499, https:\/\/doi.org\/10.1373\/clinchem.2003.026849 (2004).","journal-title":"Clinical Chemistry"},{"key":"20926_CR19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0092-8674(00)80075-6","volume":"86","author":"M Henkemeyer","year":"1996","unstructured":"Henkemeyer, M. et al. Nuk Controls Pathfinding of Commissural Axons in the Mammalian Central Nervous System. Cell 86, 35\u201346, https:\/\/doi.org\/10.1016\/S0092-8674(00)80075-6 (1996).","journal-title":"Cell"},{"key":"20926_CR20","first-page":"1001","volume":"9","author":"M Henkemeyer","year":"1994","unstructured":"Henkemeyer, M. et al. Immunolocalization of the Nuk receptor tyrosine kinase suggests roles in segmental patterning of the brain and axonogenesis. Oncogene 9, 1001\u20131014 (1994).","journal-title":"Oncogene"},{"key":"20926_CR21","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ajo.2004.04.006","volume":"138","author":"N Umeda","year":"2004","unstructured":"Umeda, N., Ozaki, H., Hayashi, H. & Oshima, K. Expression of ephrinB2 and its receptors on fibroproliferative membranes in ocular angiogenic diseases. American Journal of Ophthalmology 138, 270\u2013279, https:\/\/doi.org\/10.1016\/j.ajo.2004.04.006 (2004).","journal-title":"American Journal of Ophthalmology"},{"key":"20926_CR22","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/jid.2012.391","volume":"133","author":"K Gordon","year":"2013","unstructured":"Gordon, K. et al. Alteration of the EphA2\/Ephrin-A Signaling Axis in Psoriatic Epidermis. Journal of Investigative Dermatology 133, 712\u2013722, https:\/\/doi.org\/10.1038\/jid.2012.391 (2013).","journal-title":"Journal of Investigative Dermatology"},{"key":"20926_CR23","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.celrep.2015.09.085","volume":"13","author":"R Nunan","year":"2015","unstructured":"Nunan, R. et al. Ephrin-Bs Drive Junctional Downregulation and Actin Stress Fiber Disassembly to Enable Wound Re-epithelialization. Cell Reports 13, 1380\u20131395, https:\/\/doi.org\/10.1016\/j.celrep.2015.09.085 (2015).","journal-title":"Cell Reports"},{"key":"20926_CR24","doi-asserted-by":"publisher","first-page":"e62","DOI":"10.1371\/journal.pmed.0050062","volume":"5","author":"M Selman","year":"2008","unstructured":"Selman, M., Pardo, A. & Kaminski, N. Idiopathic Pulmonary Fibrosis: Aberrant Recapitulation of Developmental Programs? PLOS Medicine 5, e62, https:\/\/doi.org\/10.1371\/journal.pmed.0050062 (2008).","journal-title":"PLOS Medicine"},{"key":"20926_CR25","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.mcn.2009.10.008","volume":"43","author":"J Kimura-Kuroda","year":"2010","unstructured":"Kimura-Kuroda, J. et al. An in vitro model of the inhibition of axon growth in the lesion scar formed after central nervous system injury. Molecular and Cellular Neuroscience 43, 177\u2013187, https:\/\/doi.org\/10.1016\/j.mcn.2009.10.008 (2010).","journal-title":"Molecular and Cellular Neuroscience"},{"key":"20926_CR26","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1002\/hep.27792","volume":"62","author":"PN Mimche","year":"2015","unstructured":"Mimche, P. N. et al. The receptor tyrosine kinase EphB2 promotes hepatic fibrosis in mice. Hepatology 62, 900\u2013914, https:\/\/doi.org\/10.1002\/hep.27792 (2015).","journal-title":"Hepatology"},{"key":"20926_CR27","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.jhep.2005.06.025","volume":"43","author":"Y Popov","year":"2005","unstructured":"Popov, Y., Patsenker, E., Fickert, P., Trauner, M. & Schuppan, D. Mdr2 (Abcb4)\u2212\/\u2212 mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genes. Journal of Hepatology 43, 1045\u20131054, https:\/\/doi.org\/10.1016\/j.jhep.2005.06.025 (2005).","journal-title":"Journal of Hepatology"},{"key":"20926_CR28","doi-asserted-by":"publisher","first-page":"E3297","DOI":"10.1073\/pnas.1400062111","volume":"111","author":"K Iwaisako","year":"2014","unstructured":"Iwaisako, K. et al. Origin of myofibroblasts in the fibrotic liver in mice. Proceedings of the National Academy of Sciences 111, E3297\u2013E3305, https:\/\/doi.org\/10.1073\/pnas.1400062111 (2014).","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"20926_CR29","doi-asserted-by":"publisher","unstructured":"Mederacke, I. et al. Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology. Nat Commun 4, https:\/\/doi.org\/10.1038\/ncomms3823 (2013).","DOI":"10.1038\/ncomms3823"},{"key":"20926_CR30","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1038\/nm.3282","volume":"19","author":"NC Henderson","year":"2013","unstructured":"Henderson, N. C. et al. Targeting of [alpha]v integrin identifies a core molecular pathway that regulates fibrosis in several organs. Nat Med 19, 1617\u20131624, https:\/\/doi.org\/10.1038\/nm.3282, http:\/\/www.nature.com\/nm\/journal\/v19\/n12\/abs\/nm.3282.html#supplementary-information (2013).","journal-title":"Nat Med"},{"key":"20926_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5451","volume":"5","author":"I Lopez-Sanchez","year":"2014","unstructured":"Lopez-Sanchez, I. et al. GIV\/Girdin is a central hub for profibrogenic signalling networks during liver fibrosis. Nature Communications 5, 4451, https:\/\/doi.org\/10.1038\/ncomms5451, http:\/\/www.nature.com\/articles\/ncomms5451#supplementary-information (2014).","journal-title":"Nature Communications"},{"key":"20926_CR32","doi-asserted-by":"publisher","first-page":"S158","DOI":"10.1097\/01.mcg.0000155516.02468.0f","volume":"39","author":"RG Wells","year":"2005","unstructured":"Wells, R. G. The Role of Matrix Stiffness in Hepatic Stellate Cell Activation and Liver Fibrosis. Journal of Clinical Gastroenterology 39, S158\u2013S161 (2005).","journal-title":"Journal of Clinical Gastroenterology"},{"key":"20926_CR33","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrneph.2016.48","volume":"12","author":"X-m Meng","year":"2016","unstructured":"Meng, X.-m, Nikolic-Paterson, D. J. & Lan, H. Y. TGF-[beta]: the master regulator of fibrosis. Nat Rev Nephrol 12, 325\u2013338, https:\/\/doi.org\/10.1038\/nrneph.2016.48 (2016).","journal-title":"Nat Rev Nephrol"},{"key":"20926_CR34","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1056\/NEJMra1300575","volume":"372","author":"DC Rockey","year":"2015","unstructured":"Rockey, D. C., Bell, P. D. & Hill, J. A. Fibrosis \u2014 A Common Pathway to Organ Injury and Failure. New England Journal of Medicine 372, 1138\u20131149, https:\/\/doi.org\/10.1056\/NEJMra1300575 (2015).","journal-title":"New England Journal of Medicine"},{"key":"20926_CR35","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.cell.2008.03.011","volume":"133","author":"EB Pasquale","year":"2008","unstructured":"Pasquale, E. B. Eph-Ephrin Bidirectional Signaling in Physiology and Disease. Cell 133, 38\u201352, https:\/\/doi.org\/10.1016\/j.cell.2008.03.011 (2008).","journal-title":"Cell"},{"key":"20926_CR36","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/383722a0","volume":"383","author":"SJ Holland","year":"1996","unstructured":"Holland, S. J. et al. Bidirectional signalling through the EPH-family receptor Nuk and its transmembrane ligands. Nature 383, 722, https:\/\/doi.org\/10.1038\/383722a0 (1996).","journal-title":"Nature"},{"key":"20926_CR37","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1189\/jlb.0210079","volume":"88","author":"MA Stimamiglio","year":"2010","unstructured":"Stimamiglio, M. A. et al. EphB2-mediated interactions are essential for proper migration of T cell progenitors during fetal thymus colonization. Journal of Leukocyte Biology 88, 483\u2013494, https:\/\/doi.org\/10.1189\/jlb.0210079 (2010).","journal-title":"Journal of Leukocyte Biology"},{"key":"20926_CR38","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s10549-014-3147-8","volume":"148","author":"S Lam","year":"2014","unstructured":"Lam, S. et al. Wild-type p53 inhibits pro-invasive properties of TGF-\u03b23 in breast cancer, in part through regulation of EPHB2, a new TGF-\u03b2 target gene. Breast Cancer Research and Treatment 148, 7\u201318, https:\/\/doi.org\/10.1007\/s10549-014-3147-8 (2014).","journal-title":"Breast Cancer Research and Treatment"},{"key":"20926_CR39","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.bbrc.2011.01.045","volume":"405","author":"K Furukawa","year":"2011","unstructured":"Furukawa, K. et al. Smad3 contributes to positioning of proliferating cells in colonic crypts by inducing EphB receptor protein expression. Biochemical and Biophysical Research Communications 405, 521\u2013526, https:\/\/doi.org\/10.1016\/j.bbrc.2011.01.045 (2011).","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"20926_CR40","doi-asserted-by":"publisher","unstructured":"Martin, K. et al. PAK proteins and YAP-1 signalling downstream of integrin beta-1 in myofibroblasts promote liver fibrosis. Nature Communications 7, 12502, https:\/\/doi.org\/10.1038\/ncomms12502 http:\/\/www.nature.com\/articles\/ncomms12502#supplementary-information (2016).","DOI":"10.1038\/ncomms12502"},{"key":"20926_CR41","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1681\/ASN.2015050499","volume":"27","author":"SG Szeto","year":"2016","unstructured":"Szeto, S. G. et al. YAP\/TAZ Are Mechanoregulators of TGF-\u03b2-Smad Signaling and Renal Fibrogenesis. Journal of the American Society of Nephrology 27, 3117\u20133128, https:\/\/doi.org\/10.1681\/asn.2015050499 (2016).","journal-title":"Journal of the American Society of Nephrology"},{"key":"20926_CR42","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1083\/jcb.201501018","volume":"210","author":"M-T Prosp\u00e9ri","year":"2015","unstructured":"Prosp\u00e9ri, M.-T. et al. Myosin 1b functions as an effector of EphB signaling to control cell repulsion. The Journal of Cell Biology 210, 347\u2013361, https:\/\/doi.org\/10.1083\/jcb.201501018 (2015).","journal-title":"The Journal of Cell Biology"},{"key":"20926_CR43","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1172\/JCI37444","volume":"119","author":"E Seki","year":"2009","unstructured":"Seki, E. et al. CCR1 and CCR5 promote hepatic fibrosis in mice. The Journal of Clinical Investigation 119, 1858\u20131870, https:\/\/doi.org\/10.1172\/JCI37444 (2009).","journal-title":"The Journal of Clinical Investigation"},{"key":"20926_CR44","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/hep.22952","volume":"50","author":"E Seki","year":"2009","unstructured":"Seki, E. et al. CCR2 promotes hepatic fibrosis in mice. Hepatology 50, 185\u2013197, https:\/\/doi.org\/10.1002\/hep.22952 (2009).","journal-title":"Hepatology"},{"key":"20926_CR45","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1002\/jcp.25219","volume":"231","author":"PD Pozniak","year":"2016","unstructured":"Pozniak, P. D., Darbinyan, A. & Khalili, K. TNF-\u03b1\/TNFR2 Regulatory Axis Stimulates EphB2-Mediated Neuroregeneration Via Activation of NF-\u03baB. Journal of Cellular Physiology 231, 1237\u20131248, https:\/\/doi.org\/10.1002\/jcp.25219 (2016).","journal-title":"Journal of Cellular Physiology"},{"key":"20926_CR46","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1172\/JCI66369","volume":"123","author":"C Yin","year":"2013","unstructured":"Yin, C., Evason, K. J., Asahina, K. & Stainier, D. Y. R. Hepatic stellate cells in liver development, regeneration, and cancer. The Journal of Clinical Investigation 123, 1902\u20131910, https:\/\/doi.org\/10.1172\/JCI66369 (2013).","journal-title":"The Journal of Clinical Investigation"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-20926-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-20926-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-20926-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T02:14:57Z","timestamp":1671588897000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-20926-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,7]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["20926"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-20926-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,7]]},"assertion":[{"value":"17 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"2532"}}